CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-20 | Hohneker John Director | Grant or award · Non Qualified Stock Option | +14,400 | $3.13 | $45K | 14,400 |
| 2025-05-20 | GREENACRE MARTYN D Director | Grant or award · Non Qualified Stock Option | +14,400 | $3.13 | $45K | 14,400 |
| 2025-05-20 | Rubin Marc Director | Grant or award · Non Qualified Stock Option | +14,400 | $3.13 | $45K | 14,400 |
| 2025-05-20 | Duvall Diantha CFO | Grant or award · Employee stock option (right to buy) | +135,000 | $3.13 | $423K | 135,000 |
| 2025-05-20 | Borgman Anne Elizabeth Director | Grant or award · Non Qualified Stock Option | +14,400 | $3.13 | $45K | 14,400 |
| 2025-05-20 | Zung Jonathan B. CDO | Grant or award · Employee stock option (right to buy) | +135,000 | $3.13 | $423K | 135,000 |
| 2025-05-20 | KAITIN KENNETH I Director | Grant or award · Non Qualified Stock Option | +14,400 | $3.13 | $45K | 14,400 |
| 2025-05-01 | Hamdy Ahmed MD CMO | Grant or award · Employee stock option (right to buy) | +200,000 | $2.48 | $496K | 200,000 |
| 2025-01-28 | Duvall Diantha CFO | Grant or award · Employee stock option (right to buy) | +15,000 | $3.13 | $47K | 15,000 |
| 2025-01-28 | Dentzer James E President & CEO | Grant or award · Employee stock option (right to buy) | +40,000 | $3.13 | $125K | 40,000 |
| 2025-01-28 | Zung Jonathan B. CDO | Grant or award · Employee stock option (right to buy) | +15,000 | $3.13 | $47K | 15,000 |
| 2025-01-28 | KAITIN KENNETH I Director | Grant or award · Non Qualified Stock Option | +1,600 | $3.13 | $5K | 1,600 |
| 2025-01-28 | Rubin Marc Director | Grant or award · Non Qualified Stock Option | +1,600 | $3.13 | $5K | 1,600 |
| 2025-01-28 | Borgman Anne Elizabeth Director | Grant or award · Non Qualified Stock Option | +1,600 | $3.13 | $5K | 1,600 |
| 2025-01-28 | Hohneker John Director | Grant or award · Non Qualified Stock Option | +1,600 | $3.13 | $5K | 1,600 |
| 2025-01-28 | GREENACRE MARTYN D Director | Grant or award · Non Qualified Stock Option | +1,600 | $3.13 | $5K | 1,600 |
| 2024-05-21 | Duvall Diantha CFO | Grant or award · Employee stock option (right to buy) | +39,000 | $11.62 | $453K | 39,000 |
| 2024-05-21 | Dentzer James E President & CEO | Grant or award · Employee stock option (right to buy) | +100,000 | $11.62 | $1.2M | 100,000 |
| 2024-05-21 | Zung Jonathan B. CDO | Grant or award · Employee stock option (right to buy) | +40,700 | $11.62 | $473K | 40,700 |
| 2024-05-21 | KAITIN KENNETH I Director | Grant or award · Non Qualified Stock Option | +4,250 | $11.62 | $49K | 4,250 |
Page 3 of 17 · 326 trades